Calculus Capital Invests in Axol Bioscience
- On August 15, 2017
- By GrowthInvest Admin
Calculus Capital invests – a leading EIS and VCT investor, has completed its third deal in two weeks as they invest £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells. Founded in Cambridge by Dr Yichen Shi together with experienced entrepeneur and 2017 NED of the year, Johnathon Milner.
Read the full article here.
Source: Calculus Capital
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest